Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 164   

Articles published

BMY 75.56 -0.12 (-0.16%)
price chart
What Wall Street is saying about Bristol-Myers Squibb Co (NYSE:BMY)
Bristol-Myers Squibb Co (NYSE:BMY) stock is currently trading at about $75.68 and lots of rating firms seem to have a target price set on the stock.
Analyst Recommended Stock: Bristol-Myers Squibb Company (NYSE:BMY)  News Oracle
AbbVie and Bristol-Myers Squibb to collaborate on lung cancer clinical trial  MarketWatch
Office Depot Inc (NASDAQ:ODP) & Bristol-Myers Squibb Co (NYSE:BMY) Trend ...
Bristol-Myers Squibb Company (BMY) declared the commercial launch of the ORENCIA ClickJectTM Autoinjector, a new self-administered autoinjector for adults with moderate to severe rheumatoid arthritis (RA).
Price Target Summary: Bristol-Myers Squibb Company (NYSE:BMY)  News Oracle
Private Trust Co Na Lowers stake in Bristol-Myers Squibb Co (BMY)  TheFounders Daily
Bristol-Myers Squibb Gets CHMP's Positive Opinion For ORENCIA
Bristol-Myers Squibb Company (NYSE: BMY) disclosed the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has provided a positive opinion.
Bristol-Myers Squibb (BMY) Receives Positive CHMP Opinion on ORENCIA  StreetInsider.com
CHMP issues positive opinion for Orencia combined with methotrexate for ...  Healio
Bristol-Myers Squibb Acquires Cormorant Pharmaceuticals
NEW YORK & STOCKHOLM--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Cormorant Pharmaceuticals announced today that Bristol-Myers Squibb has acquired all of the outstanding capital stock of Cormorant, a private, Stockholm, ...
Bristol-Myers buys Swedish company with immunotherapy treatment  MarketWatch
Bristol-Myers Squibb Co (NYSE:BMY) close to 52-week high, short interest ...  Street Report
Bristol-Myers Squibb Company (NYSE:BMY) Given Price Target Of $74.571
As per Bristol-Myers Squibb Company (NYSE:BMY)'s news release on 2016-06-13, its shareholders will get cash dividend of $0.38 per share.
Where Bristol-Myers Squibb Co (NYSE:BMY) Is Betting $520 Million
Bristol-Myers Squibb Co (NYSE:BMY) has agreed to acquire privately-held Cormorant Pharmaceuticals. Boards on both sides and shareholders on the side of Cormorant have approved the buyout.
Newman Dignan Sheerar Lowers stake in Bristol-Myers Squibb Co (BMY)  Trade Calls
Bristol-Myers Squibb Co (NYSE:BMY)Analyst Research Summary:
Bristol-Myers Squibb Co (NYSE:BMY)stock is currently trading at about $70.32 and lots of rating firms seem to have a target price set on the stock.
Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for June 29, 2016  Nasdaq
Bristol-Myers Squibb Co (BMY) Bucks Market Sell-Off on Upbeat Drug News  Schaeffers Research (blog)
Shares Providing Gains on the Year: Bristol-Myers Squibb Company (NYSE:BMY)
Year to date, Bristol-Myers Squibb Company (NYSE:BMY) stock has yielded positive results for investors. So far this year the stock has jumped 11.08% as investors are hopeful that the trend can continue into the 2nd half of 2016.
The Growth Forecast For Bristol-Myers Squibb Company (NYSE:BMY)
Wall Street renowned brokerages following Bristol-Myers Squibb Company (NYSE:BMY) have now given a mean price target of $74.571 on its stock.
Bristol-Myers Squibb (BMY) Shares Cross 2% Yield Mark
Looking at the universe of stocks we cover at Dividend Channel , in trading on Friday, shares of Bristol-Myers Squibb Co. (Symbol: BMY) were yielding above the 2% mark based on its quarterly dividend (annualized to $1.52), with the stock changing hands ...